Bio-Rad Laboratories Inc. has launched five new ddPCR Mutliplex Mutation Screening Kits. The kits screen for multiple key actionable cancer mutations and wild type in a single reaction from both formalin-fixed, paraffin-embedded (FFPE) and liquid biopsy sources. The new ddPCR Multiplex Mutation Screening Kits detect mutations in BRAF, KRAS and NRAS genes associated with numerous cancers, including lung, colorectal, ovarian, thyroid, melanoma, breast and pancreatic cancer.